Understanding mortality trends in patients with uterine malignancies from 1999 to 2023 utilizing the CDC WONDER database
Journal of Gynecologic Oncology · 2026 · 37
DOI: 10.3802/jgo.2026.37.e143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Shannon Blee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Creighton University School of Medicine, Omaha, NE, USA. Smb48214@creighton.edu. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Creighton University School of Medicine, Omaha, NE, USA. Smb48214@creighton.edu.
- Creighton University School of Medicine, Omaha, NE, USA.
- Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE, USA.
- Department of Hematology and Oncology, Creighton University School of Medicine, Omaha, NE, USA.
ORCID-Profile: Shannon Blee, Sun Young Guwn, Olivia Foley, Taylor Billion, Peter Silberstein, Abubakar Tauseef
Zitieren
APA
Blee, S., Guwn, S. Y., Foley, O., Billion, T., Silberstein, P., & Tauseef, A. (2026). Understanding mortality trends in patients with uterine malignancies from 1999 to 2023 utilizing the CDC WONDER database. Journal of Gynecologic Oncology, 37. https://doi.org/10.3802/jgo.2026.37.e143
Vancouver
Blee S, Guwn SY, Foley O, Billion T, Silberstein P, Tauseef A. Understanding mortality trends in patients with uterine malignancies from 1999 to 2023 utilizing the CDC WONDER database. Journal of Gynecologic Oncology. 2026;37. doi:10.3802/jgo.2026.37.e143
BibTeX
@article{Blee2026,
author = {Blee, Shannon and Guwn, Sun Young and Foley, Olivia and Billion, Taylor and Silberstein, Peter and Tauseef, Abubakar},
title = {Understanding mortality trends in patients with uterine malignancies from 1999 to 2023 utilizing the CDC WONDER database},
journal = {Journal of Gynecologic Oncology},
year = {2026},
volume = {37},
doi = {10.3802/jgo.2026.37.e143}
}
EUVIMED